Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis

Por van Helden, E. J., Menke-van der Houven van Oordt, C. W., Heymans, M. W., Ket, J. C. F., van den Oord, R., Verheul, H. M. W.
Publicado no Cancer Metastasis Rev (2017)

Pheochromocytoma mimicking an acute myocardial infarction

Por Menke-van der Houven van Oordt, C.W., Twickler, Th.B., van Asperdt, F.G.M.H., Ackermans, P., Timmers, H.J.L.M., Hermus, A.R.R.M.
Publicado em 2007

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

Por Goos, J A C M, Hiemstra, A C, Coupé, V M H, Diosdado, B, Kooijman, W, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Menke-van der Houven van Oordt, C W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Publicado em 2014